{"TopicDetails": {"type": 0, "ccm2Id": 46775850, "cftId": 0, "identifier": "DIGITAL-2024-AI-06-IMAGING", "title": "AI in support of Quantum-Enhanced Metabolic Magnetic Resonance Imaging Systems", "publicationDateLong": 1707955200000, "callIdentifier": "DIGITAL-2024-AI-06", "callTitle": "Cloud, data and artificial intelligence", "callccm2Id": 46775993, "allowPartnerSearch": true, "frameworkProgramme": {"id": 43152860, "abbreviation": "DIGITAL", "description": "Digital Europe Programme (DIGITAL)"}, "programmeDivision": [{"id": 43152869, "abbreviation": "DIGITAL-1-1", "description": "DIGITAL"}, {"id": 43152865, "abbreviation": "DIGITAL-1", "description": "DIGITAL-1"}], "topicMGAs": [], "tags": ["Magnetic resonance imaging", "AI models", "cancer imaging", "neurological imaging"], "keywords": ["Artificial intelligence, intelligent systems, mult", "Quantum Technologies (computing/communication)", "Health care", "Artificial intelligence", "Artificial Intelligence", "Digital Agenda"], "flags": ["AI", "DigitalAgenda"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "DIGITAL-SME Digital SME Support Actions", "typeOfMGA": [{"id": 43140990, "abbreviation": "DIGITAL-AG", "description": "DIGITAL Action Grant Budget-Based"}]}], "plannedOpeningDate": "29 February 2024", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["29 May 2024"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3541645": [{"action": "DIGITAL-2024-AI-06-LANGUAGE-02 - DIGITAL-CSA DIGITAL Coordination and Support Actions", "plannedOpeningDate": "29 February 2024", "deadlineModel": "single-stage", "deadlineDates": ["29 May 2024"], "budgetYearMap": {"2024": 4000000}, "budgetTopicActionMap": {}}], "3541647": [{"action": "DIGITAL-2024-AI-06-FINETUNE - DIGITAL-SME Digital SME Support Actions", "plannedOpeningDate": "29 February 2024", "deadlineModel": "single-stage", "deadlineDates": ["29 May 2024"], "budgetYearMap": {"2024": 25000000}, "budgetTopicActionMap": {}}], "3541649": [{"action": "DIGITAL-2024-AI-06-LANGUAGE-01 - DIGITAL-SIMPLE DIGITAL Simple Grants", "plannedOpeningDate": "29 February 2024", "deadlineModel": "single-stage", "deadlineDates": ["29 May 2024"], "budgetYearMap": {"2024": 20000000}, "budgetTopicActionMap": {}}], "3541651": [{"action": "DIGITAL-2024-AI-06-IMAGING - DIGITAL-SME Digital SME Support Actions", "plannedOpeningDate": "29 February 2024", "deadlineModel": "single-stage", "deadlineDates": ["29 May 2024"], "budgetYearMap": {"2024": 5000000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2024"]}, "description": "<SPAN class=\"topicdescriptionkind\">ExpectedOutcome</SPAN>:<p><strong>Outcomes and deliverables</strong></p><p>In phase 1:</p><ul level=\"0\"><li>Validation of the capabilities of metabolic MRI in a pre-clinical context as a diagnostic tool for cancer and neurological diseases and identifying appropriate treatments. This includes benchmarking of the success rate in finding effective cancer therapy within a relevant time frame, treatment responsiveness, recovery time and accuracy of treatment efficacy prediction.</li><li>The development of AI/machine learning techniques for cancer imaging and/or neurological imaging, e.g. by analysis of datasets accessible via the cloud, via the creation of an experimental AI/machine learning model.</li><li>Contribution to European and national initiatives on cancer imaging, and the future European Health Data Space.</li> </ul><p>In phase 2:</p><ul level=\"0\"><li>Benchmark metabolic MRI against standard MRI and other standard diagnostic tools by performing clinical trials in patients.</li><li>Operational impact of introducing metabolic MRI in hospitals, including financial implications and number of patients treated.</li><li>Assessment of metabolic MRI combined with AI techniques as a means to detect early signs or support the diagnosis of Alzheimer\u2019s disease and/or multiple sclerosis.</li><li>Standard procedures and best practices for the use of quantum-enhanced metabolic MRI in combination with AI techniques for cancer imaging and/or neurological imaging as a contribution to preparations for the wide use of this technology in European hospitals. Recommendations should be application/diagnosis-specific and mention, among other parameters, the preferred metabolic agent and the number and duration of metabolic MRI scan intervals.</li><li>Extended AI models as a tool for diagnosis, treatment selection and decision-making, and the evaluation of medical outcomes, including assessment of correlations between metabolic MRI imaging data and treatment success, in line and coordination with the European Cancer Imaging Initiative.</li><li>Use project results to contribute to European and national initiatives on cancer imaging, and in line with the future European Health Data Space.</li> </ul>\n<SPAN class=\"topicdescriptionkind\">Objective</SPAN>:<p>Magnetic resonance imaging (MRI) is a powerful tool for detecting, diagnosing and monitoring a wide range of medical conditions. An emerging approach based on quantum-enhanced metabolic MRI enables detection of the tissue metabolism, down to the cell level, leading to a much higher precision of detection and analysis of the human body. In combination with artificial intelligence (AI) and/or machine learning techniques to analyse the vast amount of data generated and for image analysis, it will lead to faster, more accurate and personalized diagnosis, treatment and follow-up notably of cancer and/or neurological disorders. The overall aim of this action is to prepare for the industrialisation and deployment of such emerging systems, with a focus on cancer imaging and/or neurological imaging.</p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>Metabolic MRI has the potential to provide information about changes in tissue metabolism which can precede macroscopic tissue changes seen with standard MRI. For example, this emerging technology can provide early detection of changes in tissue metabolism and fast feedback on treatment effectiveness, a crucial aspect of finding effective cancer therapy. The development of AI techniques for the analysis of quantum-enhanced metabolic MRI images could substantially enhance the capabilities of this new technology, transforming the process into a more automated, personalised and efficient one.</p><p>Therefore, the scope of this call is to develop and experimentally validate in an hospital environment a more precise and faster tool for the study, diagnosis, treatment and follow-up of cancer and/or neurological disorders (such as Alzheimer\u2019s disease and multiple sclerosis) by enhancing existing MRI systems with quantum-enhanced metabolic MRI and AI techniques. The project will include the deployment of innovative automated polariser systems for quantum enhanced metabolic MRI in at least two research hospitals in two different Member States, working in close collaboration. The systems should allow for fast turnover and generation of metabolic agents within a few minutes, without the need for operating such systems at cryogenic temperatures.</p><p>The polarisation level should be sufficiently high such that a metabolic MRI scan can be performed in a single-shot experiment, shortly after injecting the metabolic agent into a living organism. The project will also underpin the development of one or several AI models for the analysis of metabolic MRI data. To this end the images generated in the course of the project will be collected and annotated. These images, duly anonymised, will, together with images from other European 90 initiatives and other clinical datasets, will be used to train one or several AI models useful for the development of new diagnostic and treatment selection protocols. The project should be designed in in two phases. The start of the second phase should be conditional of the successful completion of the first phase:</p><p>Project Phase 1:</p><ul level=\"0\"><li> Deployment and validation in a pre-clinical environment of two first-generation polariser systems for the refinement of hyperpolarisation techniques, metabolic agents, MRI sequences, and signal detection to optimise the visualisation of metabolism in a range of tissues with different pathologies.</li><li>Creation of an initial experimental AI model to analyse the MRI images in combination with inputs from other sources and forms of medical analysis, including, where relevant, datasets accessible via the cloud, with a view to developing future diagnostic and treatment selection protocols.</li> </ul><p>Project Phase 2:</p><ul level=\"0\"><li>The second phase consists of the deployment and validation in a clinical environment of two second-generation polariser systems and associated AI techniques (including the training of new models if necessary) to investigate tumour growth and disease progression, diagnosis, treatment selection and decision-making, and the evaluation of medical outcomes, as well as evaluate and optimise treatment of cancer and/or neurological diseases.</li> </ul>\n", "conditions": "<p><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\">Conditions<br />\r\n<br type=\"_moz\" />\r\n</span></b></p>\r\n<p><b><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:&#10;text1;mso-themetint:191;mso-ansi-language:EN-US\">1.&nbsp;</span></b><b><span lang=\"EN-US\">Admissibility conditions: </span></b><span lang=\"EN-US\">described in section 5 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/digital/wp-call/2024/call-fiche_digital-2024-ai-06_en.pdf\" target=\"_blank\">call document</a></span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/digital/wp-call/2024/call-fiche_digital-2024-ai-06_en.pdf\" target=\"_blank\">&nbsp;</a></p>\n<p><b><span lang=\"EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\">&nbsp;described in Part B of the Application Form available in the Submission System</span></p>\n<p><b><span lang=\"EN-US\">2. Eligible countries:&nbsp;</span></b><span lang=\"EN-US\">described in section 6 of of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/digital/wp-call/2024/call-fiche_digital-2024-ai-06_en.pdf\" target=\"_blank\">call document</a></span></p>\n<p><b><span lang=\"EN-US\">3. Other eligibility conditions:</span></b><span lang=\"EN-US\">&nbsp;described in section 6 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/digital/wp-call/2024/call-fiche_digital-2024-ai-06_en.pdf\" target=\"_blank\">call document</a></span></p>\n<p><b>4. Financial and operational capacity and exclusion:&nbsp;</b>described in&nbsp;<span lang=\"EN-US\">section 7 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/digital/wp-call/2024/call-fiche_digital-2024-ai-06_en.pdf\" target=\"_blank\">call document</a></span></p>\n<p><b><span lang=\"FR-BE\">5.&nbsp;Evaluation and award:</span></b></p>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Award criteria, scoring and thresholds:</span></b><span lang=\"EN-US\">&nbsp;described in section 9 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/digital/wp-call/2024/call-fiche_digital-2024-ai-06_en.pdf\" target=\"_blank\">call document</a></span></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">Submission and evaluation processes</span></b><b><span lang=\"EN-US\">:</span></b><span lang=\"EN-US\">&nbsp;described&nbsp;<span style=\"color: rgb(64, 64, 64);\">section 8 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/digital/wp-call/2024/call-fiche_digital-2024-ai-06_en.pdf\" target=\"_blank\">call document</a> and the</span>&nbsp;</span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span lang=\"EN-US\">Online Manual</span></a></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Indicative timeline for evaluation and grant agreement:&nbsp;</span></b><span lang=\"EN-US\">described in section 4 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/digital/wp-call/2024/call-fiche_digital-2024-ai-06_en.pdf\" target=\"_blank\">call document</a></span></li>\r\n</ul>\n<p><b><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">6</span></b><b><span lang=\"EN-US\">. Legal and financial set-up of the grants:&nbsp;</span></b><span lang=\"EN-US\">described&nbsp;<span style=\"color: rgb(64, 64, 64);\">in section 10 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/digital/wp-call/2024/call-fiche_digital-2024-ai-06_en.pdf\" target=\"_blank\">call document</a></span></span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\">Documents<br />\r\n</span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\">Call document is available <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/digital/wp-call/2024/call-fiche_digital-2024-ai-06_en.pdf\" target=\"_blank\">here</a><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;mso-ansi-language:&#10;EN-US\">Standard application form </span><span style=\"color:#404040;&#10;mso-themecolor:text1;mso-themetint:191\">&mdash;</span><i style=\"mso-bidi-font-style:&#10;normal\"><span style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\"> <span lang=\"EN-US\">call-specific application form is available in the Submission System</span></span></i><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;mso-ansi-language:&#10;EN-US\"> <o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px 0px 0.0001pt; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">Detailed budget table - available in the Submission System<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px 0px 4pt; line-height: normal; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><span style=\"color: rgb(64, 64, 64);\">DIGITAL EUROPE PROGRAMME&nbsp;<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/digital/agr-contr/mga_dep_en.pdf\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">General MGA v1.0</a><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px 0px 4pt; line-height: normal; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/digital/guidance/classification-of-information-in-dep-projects_dep_en.pdf\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">Guidance Classification of information in DIGITAL projects</a></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\">Guidelines on<i>&nbsp;</i><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/how-to-complete-your-ethics-self-assessment_en.pdf\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">How to Complete your Ethics Self-Assessment</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/guidance-participation-in-dep-he-edf-cef-dig-restricted-calls_dep-he-edf-cef-dig_en.pdf\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">Guidance on participation in DEP - restricted calls</a>&nbsp;</p>\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\">Digital Europe <a href=\"https://ec.europa.eu/newsroom/dae/redirection/document/100740\" target=\"_blank\">Work Programme 2023-2024</a></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\">Digital Europe Programme&nbsp;<span lang=\"EN-US\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0694\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\">Regulation 2021/694</a></span><o:p></o:p></p>\r\n<p class=\"MsoNormal\" style=\"padding: 3px 0px; margin: 0px; line-height: 1.5; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\" style=\"color: rgb(40, 151, 183); text-decoration-line: none;\"><span lang=\"EN-US\">EU Financial Regulation 2018/1046</span></a></p>", "supportInfo": "<p><span style=\"font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\">For help related to this call, please contact us&nbsp;</span><a href=\"https://european-union.europa.eu/contact-eu/write-us_en\" target=\"_blank\" style=\"color: rgb(40, 151, 183); text-decoration-line: none; font-family: eui-light, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 12.6px; background-color: rgb(198, 219, 239);\">here</a></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;grantAndTendertype=1;categories=p_submission_eval;programme=null;actions=;keyword=;period=null\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Funding &amp; Tenders Portal FAQ</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Submission of proposals.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">IT Helpdesk</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Contact the IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Online+Manual\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Online Manual</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Step-by-step online guide through the Portal processes from proposal preparation and submission to reporting on your on-going project. Valid for all 2021-2027 programmes.</span></p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"additionalInfo": "<p>&nbsp;AI can bring many benefits to the economy and society. A special focus is given to AI in the healthcare sector and to language technologies  including an open-source language foundation model. New actions are also introduced, aiming at supporting the preparation of the implementation of the  future AI Act. Finally, two actions have focus on local communities, building on the smart  communities&rsquo; data infrastructure, developing the different layers of VR/AR worlds for communities  and moving towards an ecosystem of networked Local Digital Twins across the EU.&nbsp;</p>\r\n<p>The advent of generative AI, exemplified by models like ChatGPT, represents a transformative  moment in technological innovation. Yet, most of the advances are coming from regions outside  Europe and do not cover all languages equally.  Building an ecosystem around large language and AI models in Europe will provide better autonomy  for the use and sharing of European data and will reduce EU&rsquo;s dependence on technologies from  outside Europe.</p>", "latestInfos": [{"approvalDate": "Jul 31, 2024 4:50:52 PM", "lastChangeDate": "Jul 31, 2024 4:50:52 PM", "content": "<p><span lang=\"EN-IE\" style=\"mso-ansi-language:EN-IE\">For information on the evaluations results of this call we invite you to consult the Flash call info (evaluation results) in the following <a href=\"https://ec.europa.eu/newsroom/dae/redirection/document/107637\" target=\"_blank\">link</a>.</span></p>\r\n<p>&nbsp;</p>"}, {"approvalDate": "May 21, 2024 4:15:35 PM", "lastChangeDate": "May 21, 2024 4:15:35 PM", "content": "<p>Please note that the call document has been amended to include&nbsp;<span style=\"font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;&#10;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ligatures:&#10;standardcontextual;mso-ansi-language:EN-IE;mso-fareast-language:EN-US;&#10;mso-bidi-language:AR-SA\">a minor update under topic&nbsp;</span>DIGITAL-2024-AI-06-FINETUNE<span style=\"font-size:11.0pt;font-family:&quot;Calibri&quot;,sans-serif;&#10;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-ligatures:&#10;standardcontextual;mso-ansi-language:EN-IE;mso-fareast-language:EN-US;&#10;mso-bidi-language:AR-SA\">&nbsp;&nbsp;(page 15 and page 25). It is to be noted that this update <u>DOES NOT modify</u> in any way the topic conditions, the eligibility or evaluation criteria and it is only relevant to this topic.</span></p>"}, {"approvalDate": "Feb 29, 2024 12:00:04 AM", "lastChangeDate": "Feb 29, 2024 12:00:04 AM", "content": "The submission session is now available for: DIGITAL-2024-AI-06-IMAGING(DIGITAL-SME), DIGITAL-2024-AI-06-LANGUAGE-01(DIGITAL-SIMPLE), DIGITAL-2024-AI-06-LANGUAGE-02(DIGITAL-CSA), DIGITAL-2024-AI-06-FINETUNE(DIGITAL-SME)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}